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Abstract
Intoduction: Burkitt Lymphoma is the fastest growing tumor in human and the commonest of  the childhood malignancies. 
Generalized lymphadenopathy is a common feature of  immunodeficiency associated Burkitt lymphoma but an uncommon pre-
sentation of  the endemic type in Human Immunodeficiency Virus (HIV) negative children.
Case presentation: The authors report a 6 year old HIV negative boy who presented with generalized lymphadenopathy, cough, 
weight loss, fever and drenching night sweat and had received native medication as well as treatment in private hospitals. His ex-
amination revealed hepatosplenomegaly, bull neck with generalized significant massive lymphadenopathy. Diagnosis was missed 
initially until a lymphnode biopsy for histology confirmed Burkitt lymphoma. He was managed on combination chemotherapy 
with complete resolution and now on follow up.
Conclusion: To the best of  our knowledge, this is the first documented report of  its kind of  endemic Burkitt lymphoma 
involving lymphnodes generally as the primary site. High index of  suspicion and early biopsy are the key in this uncommon 
presentation.                              
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Introduction
Childhood malignancies constitute a major cause of  mor-
tality in developed countries of  the world.1,2 In the de-
veloping countries, though ranking lower than infections 
and malnutrition, it contributes to childhood morbidity 
and mortality.2
Burkitt Lymphoma (BL) is the fastest growing tumor in 
human with peak duration of  about 4 weeks.3 In sub-Sa-
haran Africa, BL is still the commonest of  the childhood 
malignancies,4,5 and comprised of  3 types – endemic, 
sporadic and immunodeficiency associated types.6 The 
endemic BL involves the facial bones viz mandible, max-
illa, and orbital bones while the sporadic tends to affect 
the lymphoid tissues of  the gut and presenting with ab-
dominal involvement.6 Aside these, involvement of  other 
sites have been noted which includes the breast, ovaries, 
thyroid, testis, skin as well as presentation as leukemia.7
The immunodeficiency-associated variant of  BL occurs 
as a result of  immunosuppression and is expectedly as-
sociated with generalized lymphadenopathy.6 However, 
BL presenting with generalized lymphadenopathy in the 
absence of  immunodeficiency is usually seen in adults.6
We report an unusual case of  a 6 year old Human Im-
munodeficiency Virus (HIV) negative boy who presented 
with generalized lymphadenopathy which was histologi-
cally diagnosed as BL with good response to appropriate 
chemotherapy. The need for early histologic diagnosis es-
pecially in developing countries is highlighted.
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Case report
A.G. is a 6 year old male who presented with neck, axil-
lary and groin swellings of  1 month; cough of  1 month; 
weight loss, fever and drenching night sweat of  2 weeks 
duration. Swellings have been progressively increasing in 
size over 1 month. He received native medications and 
treatment in two different private hospitals before being 
referred to our centre due to worsening symptoms. There 
was no past history of  similar illness, admission or trans-
fusion.
Physical examination showed an acute on chronically 
ill-looking child in respiratory distress, mildly pale with 
significant generalized lymphadenopathy (cervical, sub-
mandibular, submental, axillary, inguinal), febrile (Tem-
perature 38oC) and no peripheral oedema. Positive find-
ings on systemic examination were hepatomegaly 5cm, 
splenomegaly 4cm, bull neck with mixed matted and sol-
itary firm, tender lymphadenopathy of  varying sizes. A 
provisional diagnosis of  Tuberculous Adenitis was made 
with lymphoproliferative disorder and Hodgkins Lym-
phoma as possible differentials.
Investigations done included Full Blood Count (FBC) 
showing mild anaemia (Hb 10.1g/dl), WBC with lym-
phocytosis. Retroviral screening and mantoux test were 
negative. Chest X-ray showed mediastinal, perihilar and 
hilar lymphadenopathy as abdomino-pelvic ultrasound 
revealed multiple abdomino-pelvic lymphnodes.
About 10 days on admission, he started mouth-breath-
ing with bulging soft palate and reduced airflow via nasal 
cavity. Additional diagnosis of  upper airway obstruction 
secondary to airway compression was made and he had 
tracheostomy. Lymphnode histology report obtained on 
the 16th day of  admission revealed the characteristic star-
ry sky appearance of  Burkitt Lymphoma.
Chemotherapy was commenced on the 19th day of  ad-
mission (after work up) using the National Guideline 
Protocol8 consisting of  2 weekly COMP regimen (iv Cy-
clophosphamide, Oncovin, Methotrexate and oral Pred-
nisolone) at adequate doses as well as weekly prophylactic 
intrathecal methotrexate. After the first course of  chemo-
therapy, there was marked reduction of  swellings. Follow-
ing second course, tracheostomy tube was de-cannulated 
and he was discharged home. He subsequently completed 
6 courses of  the regimen and 6 doses of  weekly intrathe-
cal methotrexate following which symptoms completely 
resolved. He is currently on 3monthly follow up visit.
  
A.G. before and after chemotherapy 
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Micrograph of the Histology of A.G. H&E, X400. There is a diffuse proliferation 
of small-sized cells with scanty cytoplasm giving a "starry-sky" appearance; 
the "stars" corresponding to large tingible-body macrophages with abundant 
pale cytoplasm (black arrows) which engulf necrotic tumour debris. 
Discussion
BL remains the commonest childhood malignancy in the 
tropics,4,5 where the endemic variety is mostly seen due to 
its link with malaria and Ebstein Barr Virus (EBV) infec-
tions.7 It occurs commonly in children between the ages 
of  5 and 15 years with peak age incidence of  5-7 years7,8 
to which our patient belongs. Typical painless swelling of  
endemic BL involves the mandible, maxilla and orbital 
bones with/without intra-oral extension as well as possi-
ble looseness or mal-alignment of  the teeth.6,7 Abdominal 
organs and nodes are the known organs of  involvement 
in sporadic BL.6 Recently, immunodeficiency-associat-
ed BL was introduced to classify those with BL arising 
as a result of  immunosuppression especially HIV.6,9 The 
features in this variety of  BL are those of  BL and HIV 
combined.
Unlike the characteristic features of  BL noted by sever-
al authors,3,5-7 our patient presented with atypical features 
(including cough, weight loss, generalized lymphadenop-
athy, pallor, fever, hepatosplenomegaly) which varied dis-
tinctly from other atypical presentations noted by work-
ers from different parts of  the world.10-12 Atypical features 
undoubtedly result in mis-diagnosis and in cases where 
diagnosis were made, it will rather give rise to delayed di-
agnosis. Mis-diagnosis and delayed diagnosis will result in 
health system delay and ultimately prolong the lag time. 
These all have association with prognosis and economic 
cost of  cancer management.13 Our patient’s unusual pre-
sentation resulted in initial mis-diagnosis, though, biopsy 
for histologic confirmation was requested then.
Following tissue biopsy, histologicexamination using 
Hematoxylin and Eosin (H&E) is employed in the diag-
nosis of  BL. Lukande and colleagues14 had documented 
a high reliability of  H&E in the diagnosis of  BL while 
immunohistochemistry is advised for cases with equiv-
ocal morphologic findings. However, as the latter is not 
readily available in resource-limited settings, histology still 
remains the gold standard.14 Our patient had diagnosis 
made on the basis of  H&E histologic examination. Early 
histology leads to early diagnosis which remains a key fac-
tor in paediatric oncology as it allows for early detection 
and timely treatment.13
Different malignancies have different characteristic his-
tologic finding. For BL, finding of  the typical starry sky 
appearance on histology supports the diagnosis. This 
was the finding in our patient as well as that of  previ-
ous workers.15-17 After histologic result, it is the consensus 
that chemotherapy be commenced promptly and in com-
bination. Diverse combination chemotherapy have been 
used in the past while new ones evolve.18-20 Considering 
availability and affordability, COMP regimen (consisting 
of  iv Cyclophosphamide, Oncovin, Methotrexate and 
oral Prednisolone), is still recommended for use in re-
source-limited centres and remains a viable and effective 
strategy in such settings as was the experience of  Da-
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vidson et al21 in South Africa. This was corroborated in 
our patient who showed complete resolution following 
COMP regimen and is doing well on follow up.
Conclusion
Atypical presentation of  BL is associated with delayed 
diagnosis leading to prolonged lag time and health sys-
tem delay. These have potential negative effects on the 
prognosis as well as worsen the economic burden of  the 
malignancy. Therefore, a high index of  suspicion and ear-
ly biopsy for histology will reduce these potential impacts 
especially in resource-limited settings.
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